Related Experiment Videos

All patients with left ventricular systolic dysfunction should be treated with an angiotensin-converting enzyme

¹Department of Medicine, University of California, San Francisco.

The American Journal of Cardiology

|August 15, 1990

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effect of nesiritide in patients with acute decompensated heart failure.

The New England journal of medicine·2011

Mode of death in heart failure: findings from the ATLAS trial.

Heart (British Cardiac Society)·2002

Congestive heart failure with preserved systolic function in a statewide sample of community hospitals.

Journal of cardiac failure·2001

Toleration of high doses of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: results from the ATLAS trial. The Assessment of Treatment with Lisinopril and Survival.

Archives of internal medicine·2001

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group.

European journal of heart failure·2000

Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial.

European heart journal·2000

See all related articles